Insiders Exelixis, Inc.

Stocks

EXEL

US30161Q1040

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 01:30:00 13/06/2026 am IST			5-day change	1st Jan Change
53.13 ^USD	-0.69%		+0.82%	+21.22%

09/06	Exelixis, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 10:40 AM
03/06	Exelixis, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 11:05 AM

Insiders

20/05	Exelixis Insider Sold Shares Worth $1,745,050, According to a Recent SEC Filing	MT
11/05	Exelixis Insider Sold Shares Worth $2,742,600, According to a Recent SEC Filing	MT
11/05	Exelixis Insider Sold Shares Worth $949,164, According to a Recent SEC Filing	MT
11/05	Exelixis Insider Sold Shares Worth $373,646, According to a Recent SEC Filing	MT
23/02	Exelixis Insider Sold Shares Worth $4,382,252, According to a Recent SEC Filing	MT
20/02	Exelixis Insider Sold Shares Worth $4,687,346, According to a Recent SEC Filing	MT
19/02	Exelixis Insider Sold Shares Worth $821,623, According to a Recent SEC Filing	MT
19/02	Exelixis Insider Sold Shares Worth $1,325,339, According to a Recent SEC Filing	MT
19/02	Exelixis Insider Sold Shares Worth $2,950,941, According to a Recent SEC Filing	MT
19/02	Exelixis Insider Sold Shares Worth $2,810,998, According to a Recent SEC Filing	MT
25/11	Exelixis Insider Sold Shares Worth $3,046,928, According to a Recent SEC Filing	MT
14/11	Exelixis Insider Sold Shares Worth $4,355,000, According to a Recent SEC Filing	MT
14/11	Exelixis Insider Sold Shares Worth $2,056,278, According to a Recent SEC Filing	MT
14/11	Exelixis Insider Sold Shares Worth $1,032,414, According to a Recent SEC Filing	MT
08/11	Exelixis, Inc. Announces Executive Changes, Effective November 7, 2025	CI
30/25/30	Exelixis announces appointment of Dana T. Aftab, Ph.D. as Executive Vice President, Research and Development	RE
30/25/30	Exelixis, Inc. Appoints Dana T. Aftab as Its Executive Vice President, Research and Development	CI
23/25/23	Exelixis Insider Sold Shares Worth $1,515,091, According to a Recent SEC Filing	MT
19/25/19	Exelixis Insider Sold Shares Worth $4,600,000, According to a Recent SEC Filing	MT
19/25/19	Exelixis Insider Sold Shares Worth $1,154,500, According to a Recent SEC Filing	MT
19/25/19	Exelixis Insider Sold Shares Worth $1,619,130, According to a Recent SEC Filing	MT
19/25/19	Exelixis Insider Sold Shares Worth $6,488,503, According to a Recent SEC Filing	MT
19/25/19	Exelixis Insider Sold Shares Worth $3,309,125, According to a Recent SEC Filing	MT
20/25/20	Exelixis Insider Sold Shares Worth $1,541,343, According to a Recent SEC Filing	MT
03/24/03	Exelixis Insider Sold Shares Worth $2,200,200, According to a Recent SEC Filing	MT